We look forward to your next visit!
Dr. Gary Lotner is retiring from full-time allergy practice after 35 years with Atlanta Allergy & Asthma.
Dr. Lotner has cared for two, sometimes three generations within families during his years as an allergist. When he joined Atlanta Allergy, there were five physicians and three locations. He was integral in helping our practice grow to one of the largest allergy and asthma groups in the country.
His medical expertise has helped guide this practice, but those of us who have worked with him for years will miss his sense of humor and genuine compassion for his friends, family, and especially his patients.
Dr. Lotner’s practices at Stockbridge and Northlake will be served by two excellent Atlanta Allergy & Asthma physicians, Dr. Keith Lenchner and Dr. Lily Hwang.
Dr. Lotner plans to travel with his wife Sandy and spend even more time with his grandchildren. He also plans to continue to make a difference in the healthcare industry and will fill in for Atlanta Allergy doctors from time to time. Dr. Lotner, we will miss you but we know you are not going far!
If you would like to send a message to Dr. Lotner, please send your email to: firstname.lastname@example.org
New Treatment Options for Allergy Patients
Recently the FDA has approved several products for patients with seasonal allergic rhinitis. These tablets, which treat grass or ragweed pollen allergies, are used daily under the tongue and are called sub-lingual allergen immunotherapy (SLIT). They are indicated for allergy patients who have sensitivities to either grass or ragweed pollens, since each tablet only treats one allergen.
Although this therapy is a new option for allergy patients, as with any medical treatment, the benefits must be balanced with the potential risks. Speak with your Atlanta Allergy & Asthma physician to see if these tablets are recommended for the management of your allergies.
Participants Needed for Asthma Research Study
Atlanta Allergy & Asthma’s Research Department is looking for qualified participants for an asthma research study. We are looking for people with uncontrolled asthma. To be considered for this study, you must:
-Be between 18 and 75 years of age
-Have received an asthma diagnosis at least one year ago
-Be taking an inhaled Corticosteroid and a second controller medication for the last 6 months, with no dose changes to these medications in the 4 weeks prior to the study.
-Have asthma that is not controlled by these medications
All study-related visits, tests, and drugs will be provided at no cost. In addition, reimbursement for time and travel may be provided.
To learn more:
Stockbridge Research - 770 996-5354 or email email@example.com
Marietta Research - 770 592-4210 or email firstname.lastname@example.org
Sign Up for Our New Patient Newsletter
Subscribe to our new Allergy Update newsletter, and you'll get practice news, updates on the latest allergy and asthma research, and more.